Breadcrumbs

Antimicrobial utilisation surveillance statistics

Surveillance of antimicrobial usage is a fundamental component of antimicrobial stewardship, and is a required action of hospitals for accreditation according to the National Safety and Quality in Health Service Standard 3 (Preventing and Controlling Healthcare Associated Infections).

National Antimicrobial Utilisation Surveillance Program (NAUSP)

The National Antimicrobial Utilisation Surveillance Program (NAUSP) collects data from over 150 major Australian Hospitals and provides reports of key antibiotic usage rates on a six monthly basis. 

De-identified peer group reports are submitted every six months to the Australian Commission on Safety and Quality in Health Care (ACSQHC). These show aggregated data collected from all NAUSP hospitals, principal referral hospitals and public acute group A hospitals. . Private hospitals are included within their appropriate peer group. Other reports show aggregated data at a state level and de-identified benchmarked data. De-identified reports by peer groups are also available.

Contributor hospitals can access individual usage rate reports which contain charts showing comparators made up of the average of usage at similarly peered hospitals through the NAUSP Portal  since January 2017. Some contributors can access reports for Intensive Care Unit, haematology/oncology, High Dependency Unit and respiratory ward specialities. 

National speciality reports are presented below, along with de-identified benchmarking reports for Intensive Care usage in Principal Referral and acute group A hospitals.

 A detailed NAUSP annual report is produced showing usage of an expanded number of antimicrobials both nationally and in individual Australian public and private hospitals in a de-identified manner.

Reports

Annual reports

2016 NAUSP Annual Report (PDF 6.3MB)

2017 Antimicrobial use in South Australian hospitals

National reports by peer group - January 2017 to December 2018

All contributing hospitals (PDF 961KB)

Principal referral hospitals (PDF 964KB)

Public acute group A hospitals (PDF 961KB) - formerly called Large Public Acute

National speciality reports - January 2017 to December 2018

Haematology / Oncology (PDF 573KB)

High Dependency Unit (PDF 526KB)

Intensive Care Unit (PDF 624KB)

Respiratory (PDF 493KB)

Statewide reports - January 2017 to December 2018

New South Wales and Australian Capital Territory (PDF 400KB)

Queensland and Northern Territory (PDF 535KB)

South Australia (PDF 409KB)

Tasmania (PDF 581KB)

Victoria (PDF 351KB)

Western Australia (PDF 431KB)

Benchmarking reports - July 2018 to December 2018

New South Wales and Australian Capital Territory with hospital data de-identified (PDF 391KB)

Queensland and Northern Territory with hospital data de-identified (PDF 315KB)

South Australia with hospital data de-identified (PDF 354KB)

Tasmania with hospital data de-identified (PDF 275KB)

Victoria with hospital data de-identified (PDF 311KB)

Western Australia with hospital data de-identified (PDF 2923KB)

Principal referral hospitals, de-identified - total hospital use (PDF 390KB)

Principal referral hospitals, de-identified - Intensive Care Unit usage (PDF 314KB)

Public acute group A hospitals, de-identified - total hospital usage (PDF 317KB)

Public acute group A hospitals, de-identified - Intensive Care Unit usage (PDF 311KB)

Public acute group B hospitals, de-identified - total hospital usage (PDF 884KB)

Public acute group C hospitals, de-identified - total hospital usage (PDF 732KB)

Disclaimer

Previously published national total-hospital antibiotic usage trend data may not be accurate because of inconsistent application of surveillance definitions for 29 Queensland public hospitals between 2013 and 2017. A process is underway to obtain and re-analyse Queensland antibiotic usage data, and to publish updated Queensland and national antibiotic usage trend data following the revised analyses.

Acknowledgement

The Australian Commission on Safety and Quality in Health Care provides funding for the development and coordination of NAUSP and analyses of NAUSP data and related reports for the AURA Surveillance System.

Further information

For further information on the antimicrobial utilisation surveillance program, contact the NAUSP coordinator.

^ Back to top